
|
 |
MSc Drug Design
| Lorcan Browne |
Yr 2011 | PhD studentship |
UCL, UK |
| Sami Jaffar |
Yr 2011 |
PhD studentship |
Oxford University, UK |
| Georgia Denning
|
Yr 2011 | Cheminformatian |
AstraZeneca, UK |
| Marco D'Alicarnasso |
Yr 2011 | PhD studentship |
University of Milan, Italy SEMM European School of Molecular Medicine |
| Fation Luca |
Yr 2011 |
Account Manager |
Genesis Medical, UK |
| Matteo Aldeghi
|
Yr 2012 |
PhD studentship | University of Oxford, UK |
| Shipra Malhotra |
Yr 2012 |
Research Assistant |
Novo Informatics, Delhi |
| April Qin
|
Yr 2012 |
PhD studentship Won job in China to work in the UK |
TUM - Technische Universität München
(see video at 0:19:15) |
| Fei Ye |
Yr 2013 |
PhD studentship |
European Molecular Biology Laboratory, Heidelberg |

Lorcan Browne
Yr 2011
PhD studentship at UCL, UK |
|
My background was primarily Organic Chemistry, but I was more interested in pursuing the Medicinal side of chemistry so the MSc in Drug design provided a great oppurtunity to devolop my knowledge and skills in this area. I chose UCL for its great reputation and for its role as one of the top research colleges in Europe.
The course itself exposed me to a range of techniques and skills; including the use of Molecular Modelling software and Statistical analysis programmes. It also delivering a broad range of lecture topics; from stem cell research and pharmacogenomics to X-ray crystallography and NMR, from both lectures in UCL and experts from industry. I plan to continue on to do a PhD and feel that this master provides a comprehensive background in many of the tools and techniques that are employed at the frontier of research today.
|
|
| |

Sami Jaffar
Yr 2011
PhD studentship at Oxford University, UK |
|
Having read a first degree in Chemistry, the MSc in Drug Design at UCL was a fantastic opportunity to equip myself with the cutting-edge techniques that drive innovation at the forefront of Big Pharma and Biotech.
The comprehensive nature of the course allowed me to develop in-depth knowledge of aspects essential to Drug Discovery & Design. Modules covering Fragment Based Drug Design, Molecular Modelling and Cheminformatics were especially interesting, with specialist lectures being delivered by leading speakers from academia and industry, such as GSK, Cresset & Astex Pharmaceuticals – providing an invaluable insight into current industry opinion.
I believe the MSc Drug Design at UCL is essential for anyone looking to gain entry into a career in Pharma or Academia. It certainly sets you apart from the 'crowd'.
|
|
| |
 Georgia Denning
Yr 2011
Cheminformatian at AstraZeneca |
|
Having studied for a BSc in Biological Sciences at the University of Exeter I found that I was intrigued by the evolution and treatment of disease and the modules studied during the MSc in Drug Design at UCL gave me a fantastic opportunity to delve further into the drug discovery process.
The broad range of topics covered during the course gave me an intricate understanding of all aspects of drug discovery, consisting of a range of cutting edge skills and techniques in molecular modelling and chemoinformatics to bioinformatics and even evaluation of patenting within the pharmaceutical industry. These skills are reinforced with an even greater theoretical knowledge via the modules studied, with lectures being delivered from leading experts in their fields whether that be academia or industry.
This course sets you up with a comprehensive knowledge and understanding that is essential to break into the world of pharma, I personally found myself drawn to the fast paced environment of industry and with much thanks due to the MSc in Drug Design at UCL I now work as a chemoinformatician for one of the worlds leading pharmaceutical companies.
|
|
|
 |
Enquiries
Dr Edith Chan
Email: edith.chan@ucl.ac.uk
Phone: +44 (0)20 7679 6710

 
|